Sector revisions AstraZeneca PLC NYSE

Stocks

Market Closed - NYSE 00:00:03 12/09/2026 +04			5-day change	1st Jan Change
160.17 ^USD	+0.33%		-1.56%	+74.23%

09-12	AstraZeneca Says Late-Stage Etcamah Breast-Cancer Trial Misses Main Goal	MT
09-12	AstraZeneca's breast cancer pill fails in late-stage trial	RE

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	ELI LILLY AND COMPANY							29
	JOHNSON & JOHNSON							22
	ABBVIE INC.							29
	ROCHE HOLDING AG							19
	NOVARTIS AG							22
	ASTRAZENECA PLC							23
	AMGEN INC.							29
	NOVO NORDISK A/S							23
	GILEAD SCIENCES, INC.							27
	PFIZER INC.							26
	VERTEX PHARMACEUTICALS INCORPORATED							27
	BRISTOL-MYERS SQUIBB COMPANY							24
	SANOFI							24
	GSK PLC							21
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							16
	BAYER AG							18
	TEVA PHARMACEUTICAL INDUSTRIES LIMITED							11
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							17
	Average							22
	Weighted average by Cap.							25